Back to search

Article

PFKP Accelerates Malignant Features in Breast Cancer

2021-02-24

Abstract excerpt

<title>Abstract</title> <p><bold>Purpose</bold> The platelet isoform of phosphofructokinase (PFKP) is one of the key enzymes in the glycolytic pathway. <italic>PFKP</italic> is highly expressed in several cancers, and it has been reported to be involved in the progression of cancer cells. However, its oncological role in breast cancer (BC) remains unclear. This study aimed to evaluate the function of PFKP in BC c...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8b2cbdd5-e972-5d14-9ee6-b79cbc2e371f
DOI
10.21203/rs.3.rs-258864/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
PFKP Accelerates Malignant Features in Breast CancerDOI 10.21203/rs.3.rs-258864/v1
PFKP is a prospective prognostic, diagnostic, immunological and drug sensitivity predictor across pan-cancerSemantic proximity
PFKP is required for chemoresistant phenotype of breast cancer through modulating the formation of CD133+ cancer stem like cells.Semantic proximity
Glycolysis rate-limiting enzyme PFKP: A pan-cancer predictor for prognostic significant, immunological correlation, and drug sensitivity predictionSemantic proximity
Phosphofructokinase-1 in Cancer: A Promising Target for Diagnosis and TherapySemantic proximity
Exploring Aerobic Energy Metabolism in Breast Cancer: A Mutational Profile of Glycolysis and Oxidative Phosphorylation.Semantic proximity
Gene expression levels of the glycolytic enzymes lactate dehydrogenase A (LDHA) and phosphofructokinase platelet (PFKP) are good predictors of survival time, recurrence and risk of death in cervical cancerSemantic proximity
Differential expression of phosphofructokinase-1 isoforms correlates with the glycolytic efficiency of breast cancer cellsSemantic proximity
Systematic pan-cancer analysis identifies 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3) as a biomarker of tumor invasion and metastasis, immunity, and prognosisSemantic proximity
Hyperglycemia induces PFKFB3 overexpression and promotes malignant phenotype of breast cancer through RAS/MAPK activation.Semantic proximity
Expression Characteristics and Significant Prognostic Values of PGK1 in Breast CancerSemantic proximity
Comprehensive analysis of PLKs expression and prognosis in breast cancer.Semantic proximity
6-phosphofructo-2-kinase as therapeutic targets in cancer based on an integrated pan-cancer study6-phosphofructo-2-kinase as therapeutic targets in cancer based on an integrated pan-cancer studySemantic proximity
Select a neighboring publication to make it the new centre.